Great American Food Chain (OTC: GAMN) Completes Merger with GreenMatter Biotech, Names Joe H. Wicker Jr. CEO

Rhea-AI Summary

Great American Food Chain (OTC: GAMN) completed a merger with GreenMatter Biotech on April 15, 2026, combining regenerative materials R&D, distribution and retail partnerships into the public company.

GreenMatter reported a profitable first year with $2.5 million in 2025 revenue. Joe H. Wicker Jr. became CEO and chairman; founder Edward Sigmond stepped down. Management cites an active product pipeline and expanding distributor relationships, positioning the combined company for growth into H2 2026 and beyond.

Positive

• Merger completed between Great American Food Chain and GreenMatter Biotech
• GreenMatter reported $2.5 million revenue in 2025
• Company reported a profitable first year for GreenMatter
• New CEO Joe H. Wicker Jr. assumes leadership and chairman role

Negative

• Founder Edward Sigmond stepped down from CEO role
• No quantified 2026 guidance provided for combined company

News Market Reaction – GAMN

+1.01%

+1.01% Session close to close

In the Apr 15 session, GAMN gained 1.01%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DALLAS, April 15, 2026 (GLOBE NEWSWIRE) -- Great American Food Chain, Inc. completes merger with GreenMatter Biotech Inc, an established materials science and biotechnology company commercializing plant-based, biodegradable alternatives to traditional plastics. A strategic milestone for the company, the merger brings existing R&D, distribution and retail partnerships in the regenerative materials space.

“GreenMatter goes into this next chapter with real momentum”, said Joe H. Wicker Jr., CEO of GreenMatter Biotech Inc. “We closed 2025 with $2.5 million in revenue and the market is moving in our direction. The demand for biodegradable materials is not a future conversation. It’s happening now, and we’ve built the product platform and the partnerships to meet it at scale. Our goal is to become a leader in the plant-based biodegradable industry. The public markets give us the visibility and the capital access to accelerate what we’ve already put in motion.”

Edward Sigmond, who served as Chairman, President and Chief Executive Officer of Great American Food Chain since its founding, steps down upon the close of the transaction. His stewardship of the company laid the groundwork for this transition.

Concurrent with the close of the transaction, Joe H. Wicker Jr. has assumed the role of Chief Executive Officer and Chairman of the Board of Directors of the company, leading GreenMatter Biotech’s next phase of growth across product development, distribution and strategic partnership.

Under Wicker’s leadership, GreenMatter Biotech moves into the public markets following a profitable first year and $2.5 million in revenue in 2025. With an active pipeline, expanding distributor relationships, and growing demand for biodegradable materials, the combined company is well positioned for continued growth into the second half of 2026 and beyond.

About GreenMatter Biotech Inc.: GreenMatter Biotech was built for a world that has moved beyond single-use plastic. The company develops plant-based materials and products designed to meet real-world expectations, delivering durability during use and biodegradability in soil after disposal. GreenMatter’s approach is grounded in a simple principle: performance and environmental responsibility can - and should - coexist.

For additional GAMN stock news and company updates, investors, distributors, and retail partners are encouraged to visit the company website at https://Greenmatterbiotech.com or OTC Markets: otcmarkets.com/stock/GAMN/profile

Forward Looking Statements: This press release contains forward-looking statements within the meaning of applicable securities laws, including projections regarding anticipated 2026 revenue. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied. GreenMatter Biotech Inc. undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.

Edward Sigmond
Phone Number: +12145079984

FAQ

What did Great American Food Chain (GAMN) announce in the April 15, 2026 merger?

The company completed a merger combining GreenMatter Biotech into GAMN and named Joe H. Wicker Jr. CEO and chairman. According to the company, the deal adds R&D, distribution and retail partnerships in plant-based biodegradable materials to the public company.

How much revenue did GreenMatter Biotech report for 2025 under GAMN's April 15, 2026 announcement?

GreenMatter reported $2.5 million in revenue for 2025, representing a profitable first year. According to the company, this revenue underpins its commercial R&D and expanding distributor relationships as it enters the public markets.

Who is the new CEO of GAMN after the April 15, 2026 merger and what is his role?

Joe H. Wicker Jr. has assumed the roles of Chief Executive Officer and Chairman of the Board. According to the company, he will lead product development, distribution expansion and strategic partnerships for GreenMatter within the public company.

What happened to Great American Food Chain's previous CEO after the GAMN merger on April 15, 2026?

Edward Sigmond stepped down from his roles as chairman, president and CEO upon closing of the transaction. According to the company, his stewardship laid groundwork for the transition to the merged business led by Wicker.

What growth outlook did GAMN provide after completing the GreenMatter merger on April 15, 2026?

The company indicated it is positioned for continued growth into the second half of 2026 and beyond, citing an active pipeline and expanding distributor relationships. According to the company, public listing gives visibility and capital access to accelerate commercialization.